Rifabutin Is active against mycobacterium abscessus complex

• Main Authors: Aziz, D.B, Low, J.L, Wu, M.-L, Gengenbacher, M, Teo, J.W.P, Dartois, V, Dick, T
• Other Authors: MEDICINE
• Format: Article
• Published: American Society for Microbiology 2020
• Subjects: amikacin; aminoglycoside; azithromycin; ciprofloxacin; clarithromycin; erythromycin; gatifloxacin; gentamicin; kanamycin; levofloxacin; linezolid; macrolide; moxifloxacin; quinolone derivative; ramoplanin; rifabutin; rifampicin; rifapentine; teicoplanin; telithromycin; tigecycline; vancomycin; tuberculostatic agent; antibiotic resistance; Article; bactericidal activity; bacterium culture; bacterium isolate; colony forming unit; controlled study; drug sensitivity; growth inhibition; lung disease; minimum bactericidal concentration; minimum inhibitory concentration; Mycobacterium abscessus; nonhuman; priority journal; atypical mycobacteriosis; drug effects; human; isolation and purification; microbial sensitivity test; microbiology; multidrug resistance; respiratory tract infection; Antibiotics, Antitubercular; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Rifabutin
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175222
• Institution: National University of Singapore

10.1128/AAC.00155-17